Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Self-assembled hexagonal liquid crystalline gels as novel ocular formulation with enhanced topical delivery of pilocarpine nitrate.

Wang X, Zhang Y, Huang J, Xia M, Liu L, Tian C, Hu R, Gui S, Chu X.

Int J Pharm. 2019 May 1;562:31-41. doi: 10.1016/j.ijpharm.2019.02.033. Epub 2019 Mar 14.

PMID:
30878587
2.

A Novel Phytantriol-Based Lyotropic Liquid Crystalline Gel for Efficient Ophthalmic Delivery of Pilocarpine Nitrate.

Wang X, Zhang Y, Huang J, Tian C, Xia M, Liu L, Li Z, Cao J, Gui S, Chu X.

AAPS PharmSciTech. 2019 Jan 2;20(1):32. doi: 10.1208/s12249-018-1248-0.

PMID:
30603986
3.

Gel in core carbosomes as novel ophthalmic vehicles with enhanced corneal permeation and residence.

Moustafa MA, El-Refaie WM, Elnaggar YSR, Abdallah OY.

Int J Pharm. 2018 Jul 30;546(1-2):166-175. doi: 10.1016/j.ijpharm.2018.05.040. Epub 2018 May 17.

PMID:
29778824
4.

HII mesophase as a drug delivery system for topical application of methyl salicylate.

Liang X, Chen YL, Jiang XJ, Wang SM, Zhang JW, Gui SY.

Eur J Pharm Sci. 2017 Mar 30;100:155-162. doi: 10.1016/j.ejps.2016.12.033. Epub 2017 Jan 4.

PMID:
28063969
5.

Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.

Hussain A, Samad A, Singh SK, Ahsan MN, Haque MW, Faruk A, Ahmed FJ.

Drug Deliv. 2016;23(2):642-47. doi: 10.3109/10717544.2014.933284. Epub 2014 Jul 11.

PMID:
25013957
6.

Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles.

Kao HJ, Lin HR, Lo YL, Yu SP.

J Pharm Pharmacol. 2006 Feb;58(2):179-86.

PMID:
16451745
7.

A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate.

Li J, Wu L, Wu W, Wang B, Wang Z, Xin H, Xu Q.

Int J Pharm. 2013 Oct 15;455(1-2):75-84. doi: 10.1016/j.ijpharm.2013.07.057. Epub 2013 Jul 31.

PMID:
23916822
8.

Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.

Gan L, Han S, Shen J, Zhu J, Zhu C, Zhang X, Gan Y.

Int J Pharm. 2010 Aug 30;396(1-2):179-87. doi: 10.1016/j.ijpharm.2010.06.015. Epub 2010 Jun 15.

PMID:
20558263
9.

Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.

Ranch KM, Maulvi FA, Naik MJ, Koli AR, Parikh RK, Shah DO.

Int J Pharm. 2019 Jan 10;554:264-275. doi: 10.1016/j.ijpharm.2018.11.016. Epub 2018 Nov 10.

PMID:
30423418
10.

Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.

El-Ridy MS, Yehia SA, Mohsen AM, El-Awdan SA, Darwish AB.

Curr Drug Deliv. 2018;15(1):122-133. doi: 10.2174/1567201814666170224141548.

PMID:
28240177
11.

Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo Evaluation.

Liu R, Wang S, Fang S, Wang J, Chen J, Huang X, He X, Liu C.

Nanoscale Res Lett. 2016 Dec;11(1):254. doi: 10.1186/s11671-016-1471-0. Epub 2016 May 17.

12.

Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.

Singh J, Chhabra G, Pathak K.

Drug Dev Ind Pharm. 2014 Sep;40(9):1223-32. doi: 10.3109/03639045.2013.814061. Epub 2013 Jul 9.

PMID:
23837522
13.

An in situ gelling liquid crystalline system based on monoglycerides and polyethylenimine for local delivery of siRNAs.

Borgheti-Cardoso LN, Depieri LV, Kooijmans SA, Diniz H, Calzzani RA, Vicentini FT, van der Meel R, Fantini MC, Iyomasa MM, Schiffelers RM, Bentley MV.

Eur J Pharm Sci. 2015 Jul 10;74:103-17. doi: 10.1016/j.ejps.2015.04.017. Epub 2015 Apr 25.

PMID:
25917525
14.

Formulation and characterization of a liquid crystalline hexagonal mesophase region of phosphatidylcholine, sorbitan monooleate, and tocopherol acetate for sustained delivery of leuprolide acetate.

Báez-Santos YM, Otte A, Mun EA, Soh BK, Song CG, Lee YN, Park K.

Int J Pharm. 2016 Nov 30;514(1):314-321. doi: 10.1016/j.ijpharm.2016.06.138.

PMID:
27863678
15.

Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies.

Abdelbary GA, Amin MM, Zakaria MY.

Drug Deliv. 2017 Nov;24(1):309-319. doi: 10.1080/10717544.2016.1247928.

PMID:
28165809
16.

Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation.

Chen Y, Lu Y, Zhong Y, Wang Q, Wu W, Gao S.

J Drug Target. 2012 Dec;20(10):856-63. doi: 10.3109/1061186X.2012.723214. Epub 2012 Oct 11.

PMID:
23050903
17.

In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride.

Miyazaki S, Suzuki S, Kawasaki N, Endo K, Takahashi A, Attwood D.

Int J Pharm. 2001 Oct 23;229(1-2):29-36.

PMID:
11604255
18.

A novel ocular delivery of brinzolamide based on gellan gum: in vitro and in vivo evaluation.

Sun J, Zhou Z.

Drug Des Devel Ther. 2018 Feb 23;12:383-389. doi: 10.2147/DDDT.S153405. eCollection 2018.

19.

Phytantriol-based in situ liquid crystals with long-term release for intra-articular administration.

Chen Y, Liang X, Ma P, Tao Y, Wu X, Wu X, Chu X, Gui S.

AAPS PharmSciTech. 2015 Aug;16(4):846-54. doi: 10.1208/s12249-014-0277-6. Epub 2015 Jan 9.

20.

Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.

Liu R, Liu Z, Zhang C, Zhang B.

J Pharm Sci. 2012 Oct;101(10):3833-44. doi: 10.1002/jps.23251. Epub 2012 Jul 5.

PMID:
22767401

Supplemental Content

Support Center